Veeva Systems offers a unified enterprise ecosystem, while Captivate® provides a faster, more
flexible, and more cost-efficient EDC solution for sponsors and CROs.
Cost is a major factor when evaluating Veeva Systems vs Captivate®. For sponsors looking to maximize ROI, the choice is clear.
Standard premium platform pricing typically seen in enterprise contracts.
Includes volume discounts and specialized programs like Weidley’s Wish.
Reduced upfront costs allow sponsors to launch trials faster without massive capital allocation.
Better cost-efficiency when managing multiple trials simultaneously across your entire pipeline.
Reduced total cost of ownership by eliminating unnecessary enterprise overhead and complexity.
Veeva Systems operates as a full ecosystem platform, which can lead to high complexity.
Veeva emphasizes heavy standardization, potentially limiting unique study needs.
Veeva implementations can be slower due to deep platform complexity.
Many sponsors evaluate alternatives to Veeva Systems for cost and agility reasons.
Switching is a strategic move to optimize clinical trial management and resource allocation.
Veeva is a strong enterprise ecosystem, but Captivate® offers a faster, more flexible, and more
cost-effective EDC solution for many sponsors and CROs.
See how Captivate® compares in a live demo tailored to your study.